Iovance Biotherapeutics Funding & Investors
Iovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
iovance.comTotal Amount Raised: $1,365,400,064
Iovance Biotherapeutics Funding Rounds
Post Ipo Equity
$150,000,000
Post Ipo Equity
$603,700,000
Post Ipo Equity
$252,200,000
Post Ipo Equity
$172,500,000
Post Ipo Equity
$150,000,000
Post Ipo Equity
$603,700,000
Post Ipo Equity
$252,200,000
Post Ipo Equity
$172,500,000
Post Ipo Equity
$100,000,000
Post Ipo Equity Investors
Quogue CapitalFrazier ManagementBroadfin CapitalOrbiMed AdvisorsPost Ipo Equity
$100,000,000
Post Ipo Equity Investors
Quogue CapitalFrazier ManagementBroadfin CapitalOrbiMed AdvisorsPost Ipo Equity
$64,000,000
Post Ipo Equity
$23,000,000
Funding info provided by Diffbot.